Correction to: Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression

Lymphoma
29/06/2020

Tamura N, et al. Int J Hematol 2020.

ABSTRACT

M. Nishikori receives honoraria from Eisai and funding from Eisai and Sumitomo Dainippon Pharmaceutical.